Company attributes
Location
B2X
Founder
AngelList URL
Pitchbook URL
Date Incorporated
2006
Number of Employees (Ranges)
11 – 50
Number of Employees
30
Full Address
20 Boulevard Bénoni Goullin 44200 Nantes France
Founded Date
2006
Phone Number
+33141506204
Total Funding Amount (USD)
27,307,000
Latest Funding Round Date
January 15, 2018
Competitors
Stock Symbol
ALPHE
Latest Funding Type
Patents Assigned (Count)
5
Wellfound ID
Country
Other attributes
Company Operating Status
Active
Pherecydes Pharma is a biotechnology company developing phage therapies for fighting bacterial infections that is headquartered in Romainville, France and was founded in 2006 by Jerome Gabard and Manuel Gea.
Funding
Series A
On December 1, 2014 Pherecydes Pharma completed their series A funding round with €1.9 million in funding from Auriga Partners.
Series B
On January 16, 2018 Pherecydes Pharma completed their series A funding round with €8.7 million in funding from Go Capital (lead investor), Omnes Capital, FaDiese, Auriga Partners, and ACE Management.
Timeline
No Timeline data yet.